Annual Congress Berlin 2008

Saturday, 04.10.2008
Sunday, 05.10.2008
Monday, 06.10.2008
Tuesday, 07.10.2008
Wednesday, 08.10.2008

Citations should be made in the following way: Authors. Title. Eur Respir J 2008; 32: Suppl. 52, abstract number.

Material from 2008:

3952 Abstracts
658 Slide presentations
316 Webcasts
96 Handouts
1824 e-posters
316 Multimedia files

Material from 2008: Show

Recent advances in the pathogenesis and treatment of asthma and COPD

Oral Presentation
Chairs: B. J. O'Connor (London, United Kingdom), R. Goldie (Adelaide, Australia)

Download all media

Association of β₂-adrenoceptor genotypes with bronchodilatory effect of tiotropium in COPD N. Umeda, T. Yoshikawa, H. Kanazawa, S. Fujimoto, K. Hirata (Osaka, Japan)
Low-dose theophylline improves lung inflammatory profile during COPD exacerbations by increasing histone deacetylase activity B. G. Cosio, A. Iglesias, A. Rios, J. Pons, E. Sala, K. Ito, P. J. Barnes, A. Agusti (Palma de Mallorca, Spain; London, United Kingdom)
Cigarette smoke-induced airway neurogenic inflammation is mediated by α,ß-unsaturated aldehydes and the TRPA1 receptor. R. Nassini, E. Andrè, B. Campi, S. Materazzi, M. Trevisani, S. Amadesi, D. Massi, C. Creminon, N. Vaksman, M. Civelli, N. Bunnett, P. Geppetti, R. Patacchini (Florence, Ferrara, Parma, Italy; San Francisco, CA, United States Of America; Gyf-sur-Yve
Restored HDAC-2 expression after corticosteroid and theophylline therapy in ex-smoker COPD patients R. Mroz, A. Holownia, E. Drost, E. Chyczewska, J. Braszko, K. Donaldson, W. MacNee (Bialystok, Poland; Edinburgh, United Kingdom)
Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis R. Stockley, C. Deng, E. Piitulainen, D. Parr, S. Shaker, M. Wencker, J. Stolk, B. Stoel, A. Dirksen (Birmingham, United Kingdom; Research Triangle Park, NC, United States Of America; Malmo, Sweden; Hellerup, Denmark; Frankfurt, Germany; Leiden, Netherlan
Advantageous toxicity profile of novel inhaled antisense oligonucleotides, TPI ASM8 and TPI 1100, following chronic dosing in monkeys R. Seguin, A. Guimond, E. Viau, P. Aube, P. Renzi, L. Paquet, N. Ferrari (Montreal/QC, Canada)
Reducing the decline of FEV₁ after a 4-year therapy with montelukast in patients with bronchial asthma B. Sposato, S. Mariotta, A. Ricci (Grosseto, Roma, Italy)
Airway neutrophils have reduced glucocorticoid receptor expression J. Plumb, B. Bhowmick, B. Malia-Milanes, T. Southworth, J. Armstrong, A. Bentley, D. Ray, D. Singh (Manchester, United Kingdom)